Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated

Can Smoking Weaken Hydroxychloroquine in Cutaneous Lupus?

At a Glance

Smoking may make hydroxychloroquine less effective for cutaneous lupus by adding chemical stress and inflammation in the skin, even when the medicine reaches the bloodstream. Quitting can improve the chance of control, but do not change hydroxychloroquine without medical advice.

When your doctor advises you to quit smoking for cutaneous lupus, it isn’t just general health advice. Observational clinical studies show that patients with cutaneous lupus who smoke have only about half the odds of successfully responding to antimalarial drugs like hydroxychloroquine (Plaquenil) compared to non-smokers [1]. Smoking may make this gold-standard medication significantly less effective by chemically fueling the very inflammation the drug is trying to stop.

Important Note: Do not stop taking or change your dose of hydroxychloroquine without your doctor’s advice. Quitting smoking can improve your chances of the medication working, but hydroxychloroquine is a long-term therapy that still provides vital benefits.

The Chemical Battle in Your Skin Cells

To understand the connection between smoking and your lupus medication, researchers look at the microscopic battle happening inside your immune system.

How Hydroxychloroquine Calms Lupus
In lupus, your immune system is hyperactive. Inside your cells are small compartments called lysosomes that act as recycling centers and immune sensors. Hydroxychloroquine works by accumulating in these lysosomes and altering their chemical environment [2]. By doing this, the drug helps block specific immune sensors—called Toll-like receptors—from sounding false alarms [3]. This turns down the volume on your immune system, which helps clear skin rashes and prevent flares.

How Smoking Creates an Override
For a long time, doctors wondered if smoking simply destroyed hydroxychloroquine in the bloodstream before it could reach the skin. However, clinical studies show that smokers and non-smokers actually have similar levels of the drug in their blood [4][5]. The medication makes it to your cells, but smoking appears to biologically override its calming effects.

Researchers propose that cigarette smoke introduces severe oxidative stress—a type of chemical damage—directly into your skin, which rapidly recruits inflammatory white blood cells called neutrophils [6]. These smoke-induced chemicals independently force your immune system to release inflammatory signals, essentially bypassing the roadblock that hydroxychloroquine set up [7][8].

Think of hydroxychloroquine as a fire extinguisher trying to put out a fire in your skin. The drug is present and functioning, but smoking adds intense inflammatory pressure that the medication simply cannot keep up with.

What This Means for Your Treatment

Because smoking can powerfully fuel skin inflammation, continuing to smoke may make your cutaneous lupus much harder to control [9].

However, if your skin isn’t clearing up, smoking is just one possible factor. Your doctor will also consider:

  • Are you protecting your skin strictly from the sun (ultraviolet light)?
  • Have you been on the medication long enough, and at the right dose?
  • Could other medications or another overlapping condition be causing the rash?

If you are struggling to quit smoking, your doctor may need to consider adding additional or alternative treatments to help control your lupus.

Quitting Safely

Tobacco dependence is a medical condition, and you do not have to tackle it alone. Talk to your care team about smoking cessation aids. Nicotine replacement patches, gums, or prescription medications do not contain the thousands of inflammatory chemicals found in cigarette smoke, and they can significantly improve your chances of quitting. Removing cigarette smoke from the equation removes a major chemical barrier, giving your hydroxychloroquine the best possible chance to calm your skin.

Common questions in this guide

Does smoking make hydroxychloroquine less effective for cutaneous lupus?
It may. Observational studies found that people with cutaneous lupus who smoke are less likely to respond to medicines such as hydroxychloroquine, even though smokers and nonsmokers can have similar drug levels in the blood. Smoking is one factor among several that can affect skin control.
How could cigarette smoke interfere with hydroxychloroquine?
Hydroxychloroquine helps quiet immune signals inside cells. Cigarette smoke can add chemical damage, recruit inflammatory cells, and trigger signals of its own, which may overpower some of the medicine’s calming effect in the skin.
Should I stop taking hydroxychloroquine if I am still smoking?
No. Do not stop taking hydroxychloroquine or change its dose without your doctor’s advice; the medicine may still provide important benefits. Tell your care team how much you smoke so they can address smoking cessation and other reasons your skin may not be improving.
Are nicotine patches or gum options if I have cutaneous lupus?
Nicotine replacement patches and gum do not contain the many inflammatory chemicals found in cigarette smoke and may support quitting. Prescription smoking-cessation medicines may also be options, but your care team should help choose an approach based on your health and other medicines.
What should my doctor check if my skin is not clearing on hydroxychloroquine?
Your clinician may review whether you use strict sun protection, have taken the medicine long enough, and are using the appropriate dose. They may also consider other medicines or overlapping conditions and whether a whole-blood hydroxychloroquine level would be useful. These checks can help identify why the rash continues.
What eye monitoring is needed during long-term hydroxychloroquine treatment?
Long-term hydroxychloroquine treatment often includes retinal screening. Ask your care team whether you are up to date and what monitoring schedule is appropriate for you.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since I am struggling to quit smoking right now, what other options or additional treatments should we consider for my skin?
  2. 2.What smoking cessation aids (like patches, gums, or prescription medications) are safest and most effective for someone with lupus?
  3. 3.Would checking a whole-blood hydroxychloroquine level be useful in my situation to ensure my dosing is correct, or should we focus on other factors?
  4. 4.Am I up to date on my recommended eye monitoring (retinal screening) for long-term hydroxychloroquine use?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature.

    Chasset F, Francès C, Barete S, et al.

    Journal of the American Academy of Dermatology 2015; (72(4)):634-9.

    PMID: 25648824
  2. 2

    Hydroxychloroquine in systemic lupus erythematosus (SLE).

    Ponticelli C, Moroni G

    Expert opinion on drug safety 2017; (16(3)):411-419 doi:10.1080/14740338.2017.1269168.

    PMID: 27927040
  3. 3

    Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells.

    Cenac C, Ducatez MF, Guéry JC

    European journal of immunology 2022; (52(1)):54-61 doi:10.1002/eji.202149361.

    PMID: 34580855
  4. 4

    Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.

    Jallouli M, Galicier L, Zahr N, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2015; (67(8)):2176-84 doi:10.1002/art.39194.

    PMID: 25989906
  5. 5

    Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.

    Yeon Lee J, Lee J, Ki Kwok S, et al.

    Arthritis care & research 2017; (69(4)):536-542 doi:10.1002/acr.22962.

    PMID: 27390146
  6. 6

    Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.

    Vazquez T, Patel J, Kodali N, et al.

    The Journal of investigative dermatology 2024; (144(6)):1262-1272.e7 doi:10.1016/j.jid.2023.10.039.

    PMID: 38086428
  7. 7

    Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.

    Lood C, Blanco LP, Purmalek MM, et al.

    Nature medicine 2016; (22(2)):146-53 doi:10.1038/nm.4027.

    PMID: 26779811
  8. 8

    Ashes to Rashes: An Exploration of the Intersection Between Smoking and Cutaneous Lupus Erythematosus.

    Homer RO, Eldaboush A, Kang D, et al.

    Biomolecules 2025; (15(9)) doi:10.3390/biom15091250.

    PMID: 41008557
  9. 9

    Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain.

    Arévalo-Bermúdez MDP, Paradela S, Balboa-Barreiro V, Fonseca E

    Lupus 2020; (29(9)):1021-1030 doi:10.1177/0961203320930094.

    PMID: 32539659

This page explains how smoking may affect hydroxychloroquine treatment for cutaneous lupus for informational purposes only and does not constitute medical advice. Do not change hydroxychloroquine or smoking-cessation medicines without guidance from your care team.

Get notified when new evidence is published on Cutaneous lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.